Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-12-14 | 2018-05-14 | 32827 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198486 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-11-10 | 2024-04-26 | 209957 |
APO-TIMOP GEL | 0.5% | SOLUTION | Resolved | 2017-03-11 | 2019-02-05 | 510 |
APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5% | 0.5% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19093 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-01-18 | 2018-03-13 | 36435 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-05-02 | 2018-07-12 | 47966 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-08 | 2019-02-05 | 48866 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-15 | 2018-11-02 | 49509 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2019-09-04 | 2020-07-29 | 92992 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2019-10-30 | 2020-03-09 | 97474 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2021-01-04 | 2021-12-13 | 130810 |
APO-TIMOP | 0.5% | SOLUTION | Actual shortage | 2024-01-05 | 2024-05-03 | 215215 |
APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-02-05 | 2020-03-06 | 105364 |
APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2023-04-27 | 2023-07-13 | 190871 |
APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2023-08-04 | 2023-08-12 | 201162 |
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Resolved | 2017-03-10 | 2018-02-26 | 402 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |